Matches in Wikidata for { <http://www.wikidata.org/entity/Q95322861> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q95322861 description "artykuł naukowy opublikowany 15 maja 2020" @default.
- Q95322861 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95322861 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95322861 description "scientific article published on 15 May 2020" @default.
- Q95322861 description "wetenschappelijk artikel" @default.
- Q95322861 description "наукова стаття, опублікована 15 травня 2020" @default.
- Q95322861 name "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 name "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 type Item @default.
- Q95322861 label "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 label "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 prefLabel "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 prefLabel "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 P1433 Q95322861-A0E27AD2-B810-44E9-BBA2-94F7D2C37C33 @default.
- Q95322861 P1476 Q95322861-FE6C8FC8-0C25-471C-8A54-1DCAEC35D9B9 @default.
- Q95322861 P2093 Q95322861-01A5FDA6-533B-4D71-B47D-FBFB2B944CCE @default.
- Q95322861 P2093 Q95322861-07998BC5-B692-4ED0-A4AD-EB6360C1173A @default.
- Q95322861 P2093 Q95322861-0AB88033-4257-476B-A3EA-087387525ADC @default.
- Q95322861 P2093 Q95322861-0F51FB42-BFFE-4CB9-A1F7-69AA611EFF72 @default.
- Q95322861 P2093 Q95322861-101A65FE-E868-44AE-8DF6-B0C04615D687 @default.
- Q95322861 P2093 Q95322861-26D12E67-A37B-4C4F-98F6-65616991E5F1 @default.
- Q95322861 P2093 Q95322861-3D4D2586-BB16-4339-AE21-962F9B96757B @default.
- Q95322861 P2093 Q95322861-419B51EE-41D1-489F-BA6C-BD8C64A631E5 @default.
- Q95322861 P2093 Q95322861-4639EA42-62DD-4C57-830C-D4987E8DB660 @default.
- Q95322861 P2093 Q95322861-52DF0933-A979-4B53-9A6A-F227E3173175 @default.
- Q95322861 P2093 Q95322861-64E5DB60-252E-4344-9EBF-E52FB5484D20 @default.
- Q95322861 P2093 Q95322861-D252002D-C5FB-4C2A-B693-3C8F8E206DB6 @default.
- Q95322861 P2093 Q95322861-EF99124B-C186-46DD-82C5-5DC1525A537F @default.
- Q95322861 P275 Q95322861-1ce39555-5ded-4404-a5e1-d3fb61eec2b1 @default.
- Q95322861 P31 Q95322861-407845E5-5233-4051-9230-2B7700357628 @default.
- Q95322861 P356 Q95322861-8B36D296-EFC0-4B72-9E4E-AB985931EBFA @default.
- Q95322861 P407 Q95322861-F873BD2B-4FF6-45D8-82AF-A8762EF2E4BA @default.
- Q95322861 P433 Q95322861-CB06361B-6C5D-4F38-8F03-BCF1DB402B24 @default.
- Q95322861 P478 Q95322861-F73AF612-D9F4-4660-86D1-16C10DAC23F5 @default.
- Q95322861 P577 Q95322861-7E170928-4249-4940-ADBC-F38D4F176A32 @default.
- Q95322861 P6216 Q95322861-86b77641-8a66-4a6d-84d3-6de26a58f6f9 @default.
- Q95322861 P698 Q95322861-C0583543-1A4C-44E0-AC0E-0D164598255D @default.
- Q95322861 P921 Q95322861-8B87B99C-E84B-4DE8-A9B8-C3E29A12E87C @default.
- Q95322861 P921 Q95322861-A6D84081-AA2C-4D7D-BC1A-292D402BF4D1 @default.
- Q95322861 P932 Q95322861-D7923356-562B-4FB8-A927-BBA19FD4C1A0 @default.
- Q95322861 P356 DIAGNOSTICS10050310 @default.
- Q95322861 P698 32429323 @default.
- Q95322861 P1433 Q27726498 @default.
- Q95322861 P1476 "Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab" @default.
- Q95322861 P2093 "Atsushi Tomioka" @default.
- Q95322861 P2093 "Chihiro Omori" @default.
- Q95322861 P2093 "Kazuki Ichikawa" @default.
- Q95322861 P2093 "Kiyohide Fujimoto" @default.
- Q95322861 P2093 "Makito Miyake" @default.
- Q95322861 P2093 "Nobumichi Tanaka" @default.
- Q95322861 P2093 "Satoshi Anai" @default.
- Q95322861 P2093 "Shunta Hori" @default.
- Q95322861 P2093 "Takuto Shimizu" @default.
- Q95322861 P2093 "Takuya Owari" @default.
- Q95322861 P2093 "Yasushi Nakai" @default.
- Q95322861 P2093 "Yoshitaka Itami" @default.
- Q95322861 P2093 "Yusuke Iemura" @default.
- Q95322861 P275 Q20007257 @default.
- Q95322861 P31 Q13442814 @default.
- Q95322861 P356 "10.3390/DIAGNOSTICS10050310" @default.
- Q95322861 P407 Q1860 @default.
- Q95322861 P433 "5" @default.
- Q95322861 P478 "10" @default.
- Q95322861 P577 "2020-05-15T00:00:00Z" @default.
- Q95322861 P6216 Q50423863 @default.
- Q95322861 P698 "32429323" @default.
- Q95322861 P921 Q13896859 @default.
- Q95322861 P921 Q1787939 @default.
- Q95322861 P932 "7277993" @default.